JC Xu
Chief Tech/Sci/R&D Officer at ADAGENE INC.
Profile
JC Xu is currently the Chief Scientific Officer at Adagene, Inc. Prior to this, she worked as the Head of Research at Bristol Myers Squibb Co. from 2017 to 2020.
From 2012 to 2017, she worked as the Biology Director at Quanticel Pharmaceuticals, Inc. and before that, she worked as the Director of Strategy & Operations at Celgene Quanticel Research, Inc. Dr. Xu holds a doctorate degree from The University of Alabama at Birmingham and another doctorate degree from Peking University Health Science Center.
JC Xu active positions
Companies | Position | Start |
---|---|---|
ADAGENE INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Former positions of JC Xu
Companies | Position | End |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Corporate Officer/Principal | 2016-12-31 |
Celgene Quanticel Research, Inc.
Celgene Quanticel Research, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Quanticel Research, Inc. provides research and development for American biopharmaceutical company. | Corporate Officer/Principal | - |
Training of JC Xu
Peking University Health Science Center | Doctorate Degree |
The University of Alabama at Birmingham | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ADAGENE INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Private companies | 2 |
---|---|
Celgene Quanticel Research, Inc.
Celgene Quanticel Research, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Quanticel Research, Inc. provides research and development for American biopharmaceutical company. | Health Technology |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- JC Xu